SCHEDULE: FMR LLC Maintains 13% Stake in Penumbra Inc.
Beneficial Ownership Disclosure
FMR LLC and Abigail P. Johnson have reported a 13.0% beneficial ownership stake in Penumbra Inc., holding over 5.1 million shares of common stock.
Summary
- FMR LLC and Abigail P. Johnson collectively beneficially own 5,100,142.02 shares of Penumbra Inc. common stock.
- This ownership represents 13.0% of the total outstanding common stock of Penumbra Inc.
- FMR LLC holds sole voting power over 5,086,654.00 shares.
- Both FMR LLC and Abigail P. Johnson hold sole dispositive power over 5,100,142.02 shares.
- The filing is an Amendment No. 10 to Schedule 13G, updating previous ownership disclosures.
- The beneficial ownership was reported as of December 31, 2025.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive signal, reflecting sustained institutional confidence in Penumbra Inc. by a major asset manager, which can reassure other investors.
Positives
- The continued significant institutional ownership by FMR LLC, a major investment management firm, signals ongoing confidence in Penumbra Inc.'s prospects.
- A 13.0% stake indicates a substantial and potentially long-term investment by a prominent institutional investor.
Industry Context
StockSavvy.ai notes that a substantial stake by a prominent asset manager like FMR LLC often indicates a positive long-term view on the company's prospects within its industry, potentially signaling confidence in Penumbra Inc.'s market position and growth strategy in the medical technology sector.
Comparison to Industry Standards
- StockSavvy.ai observes that institutional ownership levels vary across the medical device industry. While specific comparable companies are not detailed in this filing, a 13.0% stake by a single institutional entity is a significant position, often exceeding average institutional holdings in many mid-cap medical technology firms, suggesting a high conviction investment.
Stakeholder Impact
- Shareholders may view the continued significant institutional ownership as a vote of confidence, potentially stabilizing or positively influencing share price.
- Management benefits from the stability and long-term perspective that a large institutional investor can bring.
Key Dates
| Date | Description |
|---|---|
| 2023-01-03 | Effective date of Power of Attorney for FMR LLC. |
| 2023-01-10 | FMR LLC filed Schedule 13G (accession number -23-000003) referencing Power of Attorney. |
| 2023-01-26 | Effective date of Power of Attorney for Abigail P. Johnson. |
| 2023-01-31 | FMR LLC filed Schedule 13G (accession number -23-000038) referencing Abigail P. Johnson's Power of Attorney. |
| 2025-12-31 | Date of event requiring the filing of this statement (beneficial ownership reporting date). |
| 2026-02-04 | Date of filing of this Schedule 13G Amendment No. 10. |
Recommendation
holdThe filing indicates a major institutional investor, FMR LLC, maintains a substantial 13.0% stake in Penumbra Inc. This continued significant ownership suggests ongoing confidence in the company's long-term prospects, warranting a 'hold' for existing investors who may see this as validation of their investment. For new investors, it signals a company with strong institutional backing, but the filing itself does not provide new operational or financial data to justify an immediate 'buy' or 'sell' recommendation.
Keywords
Penumbra Inc, PENN, FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, Medical Devices
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.